The phosphorylation of eIF2α was shown to be critical in the diseases discussed, leading to repression of long-term memory formation and synaptic plasticity in AD [104,105], and protein aggregation and dopaminergic neurodegeneration in PD [111,112,113]. This evidence concerns the gene EIF2A and Parkinson disease.